MedPath
HSA Approval

APO-FLUTICASONE AQUEOUS NASAL SPRAY 50MCG/SPRAY

SIN13983P

APO-FLUTICASONE AQUEOUS NASAL SPRAY 50MCG/SPRAY

APO-FLUTICASONE AQUEOUS NASAL SPRAY 50MCG/SPRAY

July 5, 2011

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SPRAY, METERED

NASAL

Medical Information

R01AD08

fluticasone

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC. (RICHMOND HILL)

Active Ingredients

FLUTICASONE PROPIONATE (micronized)

0.05G/100G

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.